4-(4-methylthiophen-2-yl)thiazol-2-amine | 570407-14-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-(4-methylthiophen-2-yl)thiazol-2-amine
• 英文别名: 4-(4-Methylthiophen-2-yl)-1,3-thiazol-2-amine；4-(4-methylthiophen-2-yl)-1,3-thiazol-2-amine
• CAS: 570407-14-6
• 化学式: C₈H₈N₂S₂
• 分子量: 196.297
• InChiKey: NFAIOGXJIPWLAS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  95.4
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF
  申请人：ASTELLAS PHARMA INC.

  公开号：US20160002218A1

  公开（公告）日：2016-01-07

  [Problem] A compound which is useful as an active ingredient of a pharmaceutical composition for treating storage dysfunctions, voiding dysfunctions, and lower urinary tract diseases is provided. [Means for Solution] The present inventors have found that a thiazole derivative having pyrazine-2-carbonylamino substituted at the 2-position is an excellent muscarinic M 3 receptor positive allosteric modulator, and is useful as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M 3 receptor, thereby completing the present invention. The 2-acylaminothiazole derivative or a salt thereof of the present invention can be used as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M 3 receptor, for example, voiding dysfunctions such as underactive bladder.

  [问题]提供一种化合物，该化合物可用作治疗储存功能障碍、排尿功能障碍和下尿路疾病的药物组合物的活性成分。[解决方案]本发明人发现，在2位取代吡嗪-2-羧酰胺的噻唑衍生物是一种优秀的肌动蛋白M3受体正向变构调节剂，并且可用作预防和/或治疗与肌动蛋白M3受体引起的膀胱收缩有关的膀胱或尿路疾病的药物，从而完成了本发明。本发明的2-酰胺基噻唑衍生物或其盐可用作预防和/或治疗与肌动蛋白M3受体引起的膀胱收缩有关的膀胱或尿路疾病的药物，例如，排尿功能障碍，如无力膀胱。
• SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES
  申请人：Masarykova univerzita

  公开号：EP3556755A1

  公开（公告）日：2019-10-23

  The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

  本发明提供了结构式（1）所代表的化合物： 其中 R1、R2、R3、R4、R5、R6 如权利要求中定义。这些化合物是核酸酶的抑制剂，特别适用于增殖性疾病、神经退行性疾病和其他基因组不稳定性相关疾病的治疗和/或预防方法。
• 2-ACYLAMINOTHIAZOLE DERIVATIVE AND SALT THEREOF
  申请人：Astellas Pharma Inc.

  公开号：EP2963036B1

  公开（公告）日：2019-08-28
• 2-ACYLAMINOTHIAZOLE DERIVATIVE FOR USE IN THE PREVENTION OR TREATMENT OF BLADDER/URINARY TRACT DISEASES
  申请人：Astellas Pharma Inc.

  公开号：EP3153511B1

  公开（公告）日：2019-05-15
• US9562044B2
  申请人：——

  公开号：US9562044B2

  公开（公告）日：2017-02-07